Status: Not yet recruiting
Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma
A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggressive B-cell non-Hodgkin lymphoma.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Mwanasha Merrill, MDUpdated: May 15, 2026Locations: 2
Eligibility criteria
Participants must have confirmed CD20-positive aggressive B-cell lymphoma, inclu... [+25]
History of severe allergic or anaphylactic reactions to anti-CD20 mAb therapy or... [+18]